StonvexLoading…
StonvexStonvexStonvexCore line items from LZB's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-01-24 | Q4 2025 2025-10-25 | Q3 2025 2025-07-26 | Annual 2025 2025-04-26 |
|---|---|---|---|---|
Revenue | $1.56B | $1.01B | $492.23M | $2.11B |
Operating Income | $87.98M | $58.17M | $21.99M | $135.84M |
Net Income | $68.71M | $47.06M | $18.20M | $99.56M |
EPS (Diluted) | $1.65 | $1.14 | $0.44 | $2.35 |
Total Assets | $2.09B | $1.96B | $1.93B | $1.92B |
Total Liabilities | Not available | Not available | Not available | Not available |
Cash & Equivalents | $306.12M | $338.51M | $318.54M | $328.45M |
Free Cash Flow OCF − CapEx | $118.95M | $47.40M | $17.83M | $112.99M |
Shares Outstanding | 40.92M | 41.25M | 41.21M | 41.16M |